-
The Joint Commission on Accreditation of Healthcare Organizations in Oakbrook Terrace, IL, has issued a Sentinel Event Alert that asks health care organizations to pay special attention to how tubing and catheters are connected so dangerous misconnection errors can be prevented.
-
New indication for tacrolimus (Prograf) by Astellas Pharma US. The FDA has approved tacrolimus (Prograf), a drug that suppresses the bodys immune reaction, for the prevention of graft rejection in the recipients of heart transplants.
-
Enanta Pharmaceuticals has initiated a Phase II clinical trial for the treatment of community-acquired pneumonia in the United States and Canada for EDP-420, an investigational bridged bicyclic macrolide antibiotic for the treatment of community-acquired respiratory tract infections.
-
Since Sept. 11, 2001, terror has become a common word in the American vocabulary. A recent addition are the words dirty bomb.
-
Pharmacist counseling and follow-up are associated with lower rates of preventable adverse drug events (ADEs) after patient discharge from the hospital, a new study indicates.
-
The Center for Drug Evaluation and Research (CDER), the FDAs organization for setting and ensuring the standards for the safety and effectiveness of drugs and certain therapeutic biologic products, approved 78 new drug applications (NDAs) and two biologic license applications (BLAs) in 2005.
-
Report: More pharmacists opting for part-time work; FDA extends review period for reintroduction of natalizumab; ACCU-CHEK Ultraflex Infusion Sets recalled; AHA issues statement regarding clopidogrel (Plavix) use
-
-
-
Spanish-speaking workers in the construction industry will benefit from information featured in the updated version of OSHA's "eTool de Construcción - La Prevención De Fatalidades," posted to OSHA's web site.
